Radiosynthesis of 11-[18F] fluoroundecyltriphenylphosphonium (MitoF) as a potential mitochondria-specific positron emission tomography radiotracer

被引:6
|
作者
Li, L. [1 ]
Brichard, L. [1 ]
Larsen, L. [2 ]
Menon, D. K. [3 ]
Smith, R. A. J. [2 ]
Murphy, M. P. [4 ]
Aigbirhio, F. I. [1 ]
机构
[1] Univ Cambridge, Mol Imaging Chem Lab, Wolfson Brain Imaging Ctr, Cambridge, England
[2] Univ Otago, Dept Chem, Dunedin, New Zealand
[3] Univ Cambridge, Div Anaesthesia, Cambridge, England
[4] MRC Mitochondrial Biol Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
triphenylphosphonium; fluorine-18; mitochondria; imaging; MitoF; PET; TARGETED ANTIOXIDANT MITOQ; AGENT; CATION; THERAPEUTICS; THERAPY; DISEASE;
D O I
10.1002/jlcr.3109
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Changes in the magnitude of the mitochondrial membrane potential occur in a range of important pathologies. To assess changes in membrane potential in patients, we set out to develop an improved mitochondria-targeted positron emission tomography probe comprising a lipophilic triphenylphosphonium cation attached to a fluorine-18 radionuclide via an 11-carbon alkyl chain, which is well-established to effectively transport to and localise within mitochondria. Here, we describe the radiosynthesis of this probe, 11-[F-18]fluoroundecyl-triphenylphosphonium (MitoF), from no-carrier-added [F-18]fluoride and a fully automated synthetic protocol to prepare it in good radiochemical yields (2-3GBq at end-of-synthesis) and radiochemical purity (97-99%). Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:717 / 721
页数:5
相关论文
共 50 条
  • [21] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (10): : 511 - 522
  • [22] Labeling Strategies of Peptides with 18F for Positron Emission Tomography
    Olberg, D. E.
    Hjelstuen, O. K.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (16) : 1669 - 1679
  • [23] Focusing on [18F]-fluorinated pentoses for positron emission tomography
    Li, Xiang-Guo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [24] Standardization of Scanning for [18F] Fluorodeoxyglucose Positron Emission Tomography
    Hanna, Gerard G.
    McAleese, Jonathan
    Lynch, Tom B.
    O'Sullivan, Joe M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 831 - 832
  • [25] Radiosynthesis and Characterisation of [18F]antagomir-223: A Potential PET Radiotracer for Imaging Neuroinflammation
    Zientek, Simon
    Ramakrishnan, Nisha K.
    Alfaidi, Maha
    Kuan, Wei-Li
    Fournier, Alyson
    Moore, Craig
    Aigbirhio, Franklin
    Thompson, Stephen
    Sephton, Selena Milicevic
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S128 - S129
  • [26] Synthesis of [18F]FETO, a novel potential 11-β hydroxylase inhibitor
    Wadsak, W
    Mitterhauser, M
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (04): : 379 - 388
  • [27] Tumor-specific positron emission tomography Imaging in patients:: [18F) fluorodeoxyglucose and beyond
    Mankoff, David A.
    Eary, Janet F.
    Link, Jeanne M.
    Muzi, Mark
    Rajendran, Joseph G.
    Spence, Alexander M.
    Krohn, Kenneth A.
    CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3460 - 3469
  • [28] Evaluation of O-[18F]fluoromethyl-D-tyrosine as a radiotracer for tumor imaging with positron emission tomography
    Urakami, Takeo
    Sakai, Koichi
    Asai, Tomohiro
    Fukumoto, Dai
    Tsukada, Hideo
    Oku, Naoto
    NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (03) : 295 - 303
  • [29] Steroids labeled with 18F for imaging tumors by positron emission tomography
    Katzenellenbogen, JA
    JOURNAL OF FLUORINE CHEMISTRY, 2001, 109 (01) : 49 - 54
  • [30] Positron emission tomography imaging of cell death with [18F]FPDuramycin
    Shaobo Yao
    Kongzhen Hu
    Ganghua Tang
    Xiang Liang
    Kan Du
    Dahong Nie
    Shende Jiang
    Linquan Zang
    Apoptosis, 2014, 19 : 841 - 850